Search Results - "Michelle Cespedes"
-
1
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298
Published in Clinical infectious diseases (15-10-2018)“…Anal cancer is common in human immunodeficiency virus-infected adults. This randomized trial did not find a benefit from human papillomavirus (HPV) vaccination…”
Get full text
Journal Article -
2
Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women
Published in Clinical infectious diseases (01-07-2014)“…Background. Women infected with human immunodeficiency virus (HIV) are disproportionately affected by human papillomavirus (HPV)–related anogenital disease,…”
Get full text
Journal Article -
3
Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP)
Published in PloS one (03-06-2022)“…Black and Hispanic/Latinx cisgender men who have sex with men (MSM), transgender women, transgender men, and gender nonbinary (TGNB) individuals have been…”
Get full text
Journal Article -
4
Projecting the Potential Clinical and Economic Impact of Human Immunodeficiency Virus Prevention Resource Reallocation in Tennessee
Published in Clinical infectious diseases (24-06-2024)“…In 2023, Tennessee replaced $6.2 M in US Centers for Disease Control and Prevention (CDC) human immunodeficiency virus (HIV) prevention funding with state…”
Get full text
Journal Article -
5
High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus–Infected Individuals Older Than 26 Years: ACTG 5298
Published in Sexually transmitted diseases (01-04-2018)“…BACKGROUNDThe quadrivalent human papillomavirus (HPV) vaccine (qHPV; types 6, 11, 16, 18) is indicated for men and women aged 9 to 26 years to prevent HPV…”
Get full text
Journal Article -
6
Neuropsychiatric complications of antiretroviral therapy
Published in Drug safety (01-01-2006)“…Neuropsychiatric adverse effects related to potent antiretroviral therapy are among the complications that can lead to poor adherence, treatment interruptions,…”
Get full text
Journal Article -
7
An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa
Published in Journal of lower genital tract disease (01-01-2016)“…Approximately 85% of cervical cancer cases and deaths occur in resource-constrained countries where best practices for prevention, particularly for women with…”
Get full text
Journal Article -
8
Steady-State Pharmacokinetics, Cord Blood Concentrations, and Safety of Ritonavir-Boosted Fosamprenavir in Pregnancy
Published in Journal of acquired immune deficiency syndromes (1999) (15-04-2013)“…Steady-state pharmacokinetics in pregnant women prescribed ritonavir-boosted fosamprenavir (FPV) to prevent HIV transmission were assessed in the second…”
Get full text
Journal Article -
9
A mobile health intervention in HIV primary care: supporting patients at risk for ART non-adherence
Published in HIV research & clinical practice (12-12-2020)“…Mobile health (mHealth) interventions that are integrated in HIV clinical settings to facilitate ongoing patient-provider communication between primary care…”
Get full text
Journal Article -
10
Environmental exposure and leptospirosis, Peru
Published in Emerging infectious diseases (01-06-2004)“…Human infection by leptospires has highly variable clinical manifestations, which range from subclinical infection to fulminant disease. We conducted a…”
Get full text
Journal Article -
11
Cardiovascular and Endothelial Disease in HIV Infection
Published in Current infectious disease reports (01-07-2005)“…As combination antiretroviral therapy improves outcome for HIV-infected patients, more focus is directed on the durability of these regimens and the prevention…”
Get full text
Journal Article -
12
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1
Published in Papillomavirus research (01-12-2018)“…People living with HIV have increased Human Papillomavirus (HPV) related lesions and malignancies. We describe HPV DNA recovered from the cervix and anal…”
Get full text
Journal Article -
13
Reply to Allan-Blitz and Klausner
Published in Clinical infectious diseases (01-07-2017)Get full text
Journal Article -
14
High Rates of Anal High-Grade Squamous Intraepithelial Lesions in HIV-Infected Women Who Do Not Meet Screening Guidelines
Published in Clinical infectious diseases (01-02-2017)“…Background. Human immunodeficiency virus (HIV)–infected women have a higher burden of anal high-grade squamous intraepithelial lesions (HSIL) and anal cancer…”
Get full text
Journal Article -
15
Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment
Published in HIV clinical trials (01-03-2013)“…While persistent T-cell activation has been cross-sectionally associated with poor CD4+ T-cell restoration in HIV-infected individuals maintaining…”
Get more information
Journal Article -
16
Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268
Published in HIV clinical trials (01-12-2013)“…To examine genome-wide associations in HIV-infected women with a history of cervical dysplasia compared with HIV-infected women with no history of abnormal…”
Get more information
Journal Article -
17
Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling
Published in JAMA otolaryngology-- head & neck surgery (01-01-2015)“…A new diagnosis of adult-onset recurrent respiratory papillomatosis (AO-RRP) prompts many questions related to disease acquisition, course, and transmission…”
Get more information
Journal Article -
18
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy
Published in Clinical infectious diseases (12-10-2022)“…Among antiretroviral therapy (ART)-treated people with human immunodeficiency virus (PWH), persistent systemic immune activation contributes to atherogenesis…”
Get full text
Journal Article -
19
High Rates of Anal HSIL in HIV-infected Women who do not Meet Screening Guidelines
Published in Clinical infectious diseases (04-11-2016)Get full text
Journal Article -
20
965. Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in Tennessee
Published in Open forum infectious diseases (27-11-2023)Get full text
Journal Article